By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Roskamp Institute 

2040 Whitfield Avenue

Sarasota  Florida  34243  U.S.A.
Phone: 941-752-2949 Fax: 941-752-2948


Company News
Roskamp Institute Discovers New Target For Drugs To Treat Alzheimer's Disease 10/28/2014 8:16:29 AM
Anavex Life Sciences Corp. (AVXL.OB) Agreement With The Roskamp Institute To Advance The Clinical Development Of ANAVEX PLUS 1/13/2014 9:26:39 AM
Star Scientific , Inc. Files Third-Quarter Financials For 2013; Comments On Company's Corporate Leadership Transition, Roskamp Institute Scientific Presentations At 2013 Annual Society For Neuroscience Convention 11/13/2013 8:54:07 AM
Star Scientific , Inc.'s Rock Creek Pharmaceuticals Subsidiary Enrolls First Alzheimer's Study Patient at Roskamp Institute 8/24/2012 11:26:29 AM
Rock Creek Pharmaceuticals Release: Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis 5/9/2012 9:32:32 AM
Roskamp Institute Release: Key Clinical Trial of Alzheimer’s Disease Drug Begins in Europe 2/14/2012 8:57:18 AM
Roskamp Institute Studies May Lead to Better Diagnosis and Eventual Treatment of Traumatic Brain Injuries 11/8/2011 9:41:52 AM
Alzheimer’s Disease Drug Developed at Roskamp Institute Approved for Key Clinical Trial Funding in Europe 5/25/2011 9:40:22 AM
Roskamp Institute Obtains IRB Approval for Multi-Site Human Clinical Trial with Rock Creek Pharmaceuticals RCP-006 Compound 2/28/2011 8:27:24 AM
Star Scientific , Inc. Comments on Roskamp Institute's Plans to Conduct Human Alzheimer's Clinical Trials Using a Compound (RCP-006) Developed by Rock Creek Pharmaceuticals, Inc. 10/7/2010 11:05:26 AM